NR1I2 and ovarian cancer: It has also been described that ketoconazole at 10 and 20 μM strongly enhanced cell growth inhibition and apoptosis of paclitaxel or cisplatin in ovarian cancer cells through its pregnane X receptor (PXR) antagonism.